Wait-and-See for Rescheduling as DEA Keeps Cannabis Reform on Ice Under Trump

The federal rescheduling of cannabis remains in a state of flux as the DEA confirms the process is still stalled under the current administration. While nearly 90% of Americans now back legalization, bureaucratic hurdles persist, with the decision currently sitting with an official linked to prohibitionist groups. Adding to the tension, the Senate is moving toward a ban on consumable hemp products, potentially closing the 2018 Farm Bill "loophole" that fueled the CBD and delta-8 markets. On a brighter note, Alaska is pushing for broad psychedelic reform, and courts are re-evaluating the fairness of banning cannabis users from owning firearms.

This news is a wake-up call for everyday enthusiasts. The push to ban hemp could wipe out accessible alternatives many rely on, while the rescheduling delay proves that public opinion hasn't yet overcome political red tape. For tokers, it’s a reminder that while the culture is winning the hearts of the people, the fight for fair federal laws and protected rights—like the second amendment—is far from over.